[HTML][HTML] Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
P Pauklin, T Marandi, M Kals, T Ainla… - BMC Cardiovascular …, 2023 - Springer
Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia.
P Pauklin, T Marandi, M Kals, T Ainla… - BMC …, 2023 - search.ebscohost.com
Background: Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia.
P Pauklin, T Marandi, M Kals, T Ainla… - BMC Cardiovascular …, 2023 - europepmc.org
Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
[HTML][HTML] Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
P Pauklin, T Marandi, M Kals… - BMC …, 2023 - bmccardiovascdisord.biomedcentral …
Routine oral anticoagulation (OAC) is recommended for almost all high-risk patients with
atrial fibrillation, yet registries show that OACs are still underused. Our aim was to study the …
atrial fibrillation, yet registries show that OACs are still underused. Our aim was to study the …
[HTML][HTML] Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
P Pauklin, T Marandi, M Kals, T Ainla… - BMC Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
[PDF][PDF] Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
P Pauklin, T Marandi, M Kals, T Ainla… - 2023 - bmccardiovascdisord.biomedcentral …
Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
[引用][C] Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
P Pauklin, T Marandi, M Kals, T Ainla, K Martinson… - 2023 - europepmc.org
Background Routine oral anticoagulation (OAC) is recommended for almost all high-risk
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …
patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was …